Piramal Pharma Ltd

NSE: PPLPHARMA · BSE: 543635 · Pharmaceuticals & Biotechnology · 32 announcements

Share price: ₹206.59
Market cap: ₹27,504 Cr
Revenue (annual): ₹8,869 Cr
Net profit (annual): ₹-325.9 Cr
P/E (TTM): -87.7×Sector 49.7×
Promoter holding: 34.80%-0.06% QoQ
FII holding: 12.51%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Business Update 3 Share Pledge 2 Other Announcement 2 Merger & Restructuring 2 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

30 Jul 2026 20:12 IST BSE

Annual General Meeting

Piramal Pharma Annual General Meeting

Piramal Pharma Limited concluded its 6th Annual General Meeting, where shareholders approved all resolutions, including director re-appointments, auditor remuneration, and NCD issuance authority.

Read the filing ↗